Impact of targeting the platelet-activating factor and its receptor in cancer treatment
Abstract The lipid mediator platelet-activating factor (PAF) and its receptor (PAFR) signaling play critical roles in a wide range of physiological and pathophysiological conditions, including cancer growth and metastasis. The ability of PAFR to interact with other oncogenic signaling cascades makes...
Saved in:
| Main Authors: | Kimya Qaderi, Arvin Shahmoradi, Anita Thyagarajan, Ravi P. Sahu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Military Medical Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40779-025-00597-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of the crosstalk between the PTEN and PAFR as well as PAFR and EGFR pathways in cancer
by: Anita Thyagarajan, et al.
Published: (2025-01-01) -
Metabolic Reprogramming in Toll-like Receptor-Mediated Platelet Activation
by: Lih T. Cheah, et al.
Published: (2025-06-01) -
Fucosylated Glycosaminoglycan Oligosaccharide HS14, Derived from Sea Cucumbers, Is a Novel Inhibitor of Platelet Toll-like Receptor 2
by: Huifang Sun, et al.
Published: (2025-03-01) -
BN 52021 (a platelet activating factor-receptor antagonist) decreases alveolar macrophage-mediated lung injury in experimental extrinsic allergic alveolitis
by: J-L. Pérez-Arellano, et al.
Published: (1998-01-01) -
CD39-Diannexin alleviates the platelet storage lesion by protecting platelets from activation, a new attempt from a traditional perspective
by: Cheng Liu, et al.
Published: (2025-12-01)